| ARPAZ WYETH LLC
1746220 16 Sep 2015 | on 16 Aug 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, muscular dystrophy, sickle cell disease, and anemia | | | ARPAZ WYETH LLC
A DELAWARE LIMITED LIABILITY COMPANY
1414495 14 Oct 2008 | on 04 Nov 2015 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations to treat inflammatory and autoimmune diseases and disorders, infectious diseases, metabolic diseases and disorders, diseases and disorders of the central nervous system; cardiovascular preparations; oncology preparations; preparations for the prevention and treatment of osteoporosis; human vaccines. | | | ARPAZ WYETH LLC
A DELAWARE LIMITED LIABILITY COMPANY
1388416 25 Mar 2008 | on 16 Apr 2014 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in (1) oncology, (2) the treatment of central nervous system diseases and disorders, namely Alzheimer's, (3) the treatment of inflammatory, neurological and autoimmune diseases and disorders, namely rheumatoid arthritis, multiple sclerosis and Lupus. | | | ARPAZ WYETH
(A DELAWARE CORPORATION)
1111268 31 Jul 2001 | on 24 Apr 2008 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of diabetes. | |